Prodrug based on intestinal OCTN2 carrier protein design and preparation method thereof

A prodrug and pharmaceutical technology, applied in the field of medicine, can solve the problems of low oral bioavailability and poor permeability, and achieve the effect of increasing compliance and reducing risks

Active Publication Date: 2016-07-13
SHENYANG PHARMA UNIVERSITY
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The invention is the first to synthesize a carrier prodrug targeting the intestinal OCTN2 transporter, which provide

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Prodrug based on intestinal OCTN2 carrier protein design and preparation method thereof
  • Prodrug based on intestinal OCTN2 carrier protein design and preparation method thereof
  • Prodrug based on intestinal OCTN2 carrier protein design and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0039] Example 14-Preparation of benzyl L-carnitine

[0040] 5.3 g (32.9 mmol) of L-carnitine and 4.50 g (26.3 mmol) of bromide were dissolved in 20 mL of DMF, heated to reflux at 140° C. for 2 h, and concentrated under reduced pressure to obtain 5.53 g of white solid with a yield of 83.3%. ESI-MS[M+H] + (m / z): 252 (Intermediate 1).

Example Embodiment

[0041] Example 22-Butyrate-4-benzyl-L-carnitine preparation

[0042] Dissolve 1g (3.9mmol) of intermediate and 0.48g (4.8mmol) of succinic anhydride in 10mL of DMF, add 2 drops of triethylamine at 0°C, and vacuum with nitrogen after the drops. The reaction is complete after 2h, no need for reaction The processing proceeds directly to the next step. ESI-MS[M+H] + (m / z): 352 (Intermediate 2).

Example Embodiment

[0043] Example 32 Preparation of hexanoyl-4-benzyl-L-carnitine

[0044] Dissolve 1g (3.9mmol) of intermediate and 0.59g (4.8mmol) of adipic anhydride in 10mL of DMF, add 2 drops of triethylamine at 0℃, and vacuum and protect with nitrogen. After 2h, the reaction is complete and the reaction does not require treatment. Go directly to the next step. ESI-MS[M+H] + (m / z): 380 (Intermediate 3).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of medicine and relates to a preparation method of a carrier prodrug with intestinal novel organic cation transporter 2 (OCTN2) being a target point.The preparation method includes the step of design of a prodrug structure with L/D-carnitine for modifying anti-tumor medicine containing hydroxyl or an amino group through a linker arm.The series of prodrug can improve the oral bioavailability of medicine.The invention relates to an L/D-carnitine derivative shown in the general formula I and the general formula II and pharmaceutically acceptable salt or hydrate or solvate or the pharmaceutically acceptable prodrug.Drug and R have definition given by the specification (please see the formula in specification).

Description

Technical field: [0001] The invention belongs to the technical field of medicine and relates to a class of novel compounds, in particular to a carrier prodrug targeting OCTN2 and its preparation and application. Background technique: [0002] Oral administration is currently the most common route of administration. Oral medication is relatively more convenient, safer and faster, and patients are more likely to adapt to this administration method. However, low oral bioavailability is often an important reason why many drugs cannot be administered orally. Oral absorption of drugs is affected by many factors, such as drug permeability, water solubility, pre-system metabolism and first-pass effect, and efflux of efflux transporters, etc. It is these factors that make BCS III and IV antitumor drugs Oral drug development is facing great challenges. [0003] Carrier prodrug is a prodrug strategy that targets drug transporters in vivo, such as oligopeptide transporter 1 (PEPT1) an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07H19/073C07H1/00C07D487/14A61K31/7068A61K31/407A61K47/48A61P35/00A61K47/54
Inventor 孙进王刚何仲贵王永军孙英华
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap